Peer-reviewed veterinary case report
Loss of corneal feeling in cats after 0.4% oxybuprocaine eye drops
By Giudici, Valentina et al.·Published in Veterinary ophthalmology·2015·Dé, France·View original on PubMed →
PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →
Original publication title: Corneal anesthesia following application of 0.4% oxybuprocaine hydrochloride ophthalmic solution to normal feline eyes.
- Species:
- cat
Plain-English summary
A group of 18 healthy European shorthair cats had their eyes tested to see how a numbing eye drop called oxybuprocaine affected their corneal sensitivity. After receiving the drop in one eye, the cats showed a significant loss of sensitivity for about 45 minutes, with the most profound numbness occurring just a few minutes after application. The other eye, which received a saline solution, did not show any changes. Fortunately, there were no side effects noted during the study, indicating that oxybuprocaine is safe for use in cats.
People also search for: cat eye drop numbing effect · oxybuprocaine for cats · feline corneal sensitivity test
Abstract
OBJECTIVE: To evaluate the loss and recovery of corneal sensitivity after instillation of 0.4% oxybuprocaine hydrochloride solution in the normal feline eye. ANIMAL STUDIED: Eighteen European shorthair cats free of ocular disease PROCEDURES: Baseline corneal touch threshold (CTT) readings were obtained bilaterally with a Cochet-Bonnet aesthesiometer prior to treatment. Subsequently, each cat received a single drop of 0.4% oxybuprocaine ophthalmic solution in the right eye and one drop of sterile 0.9% NaCl in the left eye to serve as control. The corneal touch threshold (CTT) of both eyes was then measured 1 min after drug administration and every 5 min for 60 min. The potential for ocular irritation following oxybuprocaine application was also evaluated. RESULTS: Baseline CTT readings were not significantly different (P > 0.05) between the control and oxybuprocaine-treated eyes with values of 1.75 ± 0.31 cm and 1.75 ± 0.30 cm, respectively. In control eyes, mean CTT did not significantly change (P > 0.05) during the study period. By contrast, after oxybuprocaine application mean CTT was significantly reduced from baseline (P < 0.05) for 45 min. Maximal corneal anesthesia, with a CTT value of 0, was achieved at 1 and 5 min in all treated eyes. A markedly reduced mean CTT of 0.14 ± 0.23 cm was still present at 20 min. Age and gender did not significantly affect corneal anesthesia. No clinically relevant ocular side effects occurred during the observation period. CONCLUSION: This is the first study that provides objective information on the depth and duration of corneal anesthesia following instillation of oxybuprocaine in healthy feline eyes.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/24824864/